retatrutide fda approval timeline 2025 Timeline: Week-by-Week Results (48 Weeks) Retatrutide: What It Is &

The Importance of Medical Oversight GLP-1s and microdosing are a hot topic right now, with everyone from online influencers to your coworkers talking about their benefits and results

Additionally, they have quick response times and are efficient in handling any customer issues

And the discontinuation rate due to adverse events runs roughly 2-3 times higher than tirzepatide at equivalent trial timepoints

Consideration GLP-1 (Semaglutide) GLP-1 + GIP (Tirzepatide) New to medical weight loss programs Want to target appetite regulation and digestion speed Need added support for insulin response & fat metabolism Have tried GLP-1 therapy before without desired results Prefer to start with one mechanism before adding a second Interested in dual-hormone approach for multiple pathways 2x weekly dosing and personalized guidance Which GLP weight loss program is right for you

The bottom line GLP-1 drugs are not a replacement for insulin, and they are not officially approved for T1D (outside of the new 2026 ADA recommendation for T1D with obesity)